To determine if these nanoparticles could deliver their payload to tumor cells successfully, the investigators utilized a construct including a gene that expresses green fluorescent protein in addition to paclitaxel and added this nanoparticle to breasts cancer tumor cells growing in lifestyle. This experiment demonstrated that gene expression did happen within the cells, and that the addition of paclitaxel had no significant influence on GFP creation. Related StoriesEntirely brand-new enzymatic process of DNA synthesisCancer DNA in patient's bloodstream may help deliver personalized treatment for liver cancerScientists explore biodegradable nanomedicine to destroy ovarian cancer cells left behind after surgeryWith this positive result in hands, the investigators then prepared a nanoparticle containing paclitaxel and a gene coding for a protein known as interkeukin-12.‘This brief genetic sequence offers been shown by other experts to behave like a bar code that may selectively prevent production of Allow-7 microRNAs,’ says Meffert. Related StoriesCharles Bonnet syndrome: an interview with Dr. Dominic ffytcheLinkam levels used in the Wolfson Bioimaging Service at the University of Bristol within the endocytic sorting study of Dr Paul VerkadeHPV study partnership signed between Beckman Coulter and IncellDxTo test if the increased loss of Allow-7 microRNAs lets BDNF boost production of particular proteins, Meffert’s group genetically engineered neurons so they could no longer decrease Let-7 microRNAs. They discovered that treating these neurons with BDNF no longer led to decreased microRNA levels or an increase in learning and memory proteins.